Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity
- PMID: 32927400
- PMCID: PMC7462642
- DOI: 10.1016/j.thromres.2020.08.043
Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity
Abstract
- •
Clinical signs are not useful for detecting DVT in critically ill COVID-19 patients
- •
DVT occurs despite full dose anticoagulation in critically ill COVID-19 patients
- •
Severe COVID-19 patients present a high prevalence of bilateral DVT
Comment on
-
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6. Ann Intern Med. 2020. PMID: 32374815 Free PMC article.
Similar articles
-
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19.Thromb Res. 2020 Dec;196:222-226. doi: 10.1016/j.thromres.2020.08.027. Epub 2020 Aug 21. Thromb Res. 2020. PMID: 32916564 Free PMC article. No abstract available.
-
Venous thromboembolism in critically ill patients affected by ARDS related to COVID-19 in Northern-West Italy.Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9154-9160. doi: 10.26355/eurrev_202009_22864. Eur Rev Med Pharmacol Sci. 2020. PMID: 32965007
-
Venous thromboembolism in non-critically ill patients with COVID-19 infection.Thromb Res. 2020 Sep;193:166-169. doi: 10.1016/j.thromres.2020.07.033. Epub 2020 Jul 17. Thromb Res. 2020. PMID: 32707275 Free PMC article.
-
Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines.Swiss Med Wkly. 2020 Jun 21;150:w20301. doi: 10.4414/smw.2020.20301. eCollection 2020 Jun 15. Swiss Med Wkly. 2020. PMID: 32640479
-
COVID-19 and Venous Thromboembolism: A Meta-analysis of Literature Studies.Semin Thromb Hemost. 2020 Oct;46(7):763-771. doi: 10.1055/s-0040-1715456. Epub 2020 Sep 3. Semin Thromb Hemost. 2020. PMID: 32882719 Free PMC article. Review.
Cited by
-
Acute Venous Disease Anomalies in Critically Ill COVID-19 Patients.Cureus. 2022 Jul 20;14(7):e27067. doi: 10.7759/cureus.27067. eCollection 2022 Jul. Cureus. 2022. PMID: 35936165 Free PMC article.
-
Risk Factors for Venous Thromboembolism in Severe COVID-19: A Study-Level Meta-Analysis of 21 Studies.Int J Environ Res Public Health. 2021 Dec 8;18(24):12944. doi: 10.3390/ijerph182412944. Int J Environ Res Public Health. 2021. PMID: 34948552 Free PMC article. Review.
-
Comparison of Standard Versus Intermediate Prophylaxis Dose for Venous Thromboembolism Prophylaxis in Patients Hospitalized With COVID-19 Infection.Hosp Pharm. 2024 Feb;59(1):94-101. doi: 10.1177/00185787231194997. Epub 2023 Aug 26. Hosp Pharm. 2024. PMID: 38223865 Free PMC article.
-
Risk of Clinically Relevant Venous Thromboembolism in Critically Ill Patients With COVID-19: A Systematic Review and Meta-Analysis.Front Med (Lausanne). 2021 Mar 9;8:647917. doi: 10.3389/fmed.2021.647917. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33768106 Free PMC article.
-
Tissue factor in COVID-19-associated coagulopathy.Thromb Res. 2022 Dec;220:35-47. doi: 10.1016/j.thromres.2022.09.025. Epub 2022 Oct 1. Thromb Res. 2022. PMID: 36265412 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical